These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38944424)
1. Melatonin Inhibits Chemical Carcinogen-mediated Malignant Transformation of Urothelial Cells: Nagata Y; Quynh NT; Aono H; Harada K; Miyamoto H; Fujimoto N Cancer Genomics Proteomics; 2024; 21(4):388-394. PubMed ID: 38944424 [TBL] [Abstract][Full Text] [Related]
2. Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression. Ide H; Inoue S; Mizushima T; Kashiwagi E; Zheng Y; Miyamoto H Mol Carcinog; 2019 Dec; 58(12):2297-2305. PubMed ID: 31535408 [TBL] [Abstract][Full Text] [Related]
3. Latrophilin-3 as a downstream effector of the androgen receptor induces urothelial tumorigenesis. Goto T; Yasui M; Teramoto Y; Nagata Y; Mizushima T; Miyamoto H Mol Carcinog; 2024 Oct; 63(10):1847-1854. PubMed ID: 38925569 [TBL] [Abstract][Full Text] [Related]
4. Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis. Kawahara T; Kashiwagi E; Li Y; Zheng Y; Miyamoto Y; Netto GJ; Ishiguro H; Miyamoto H Mol Carcinog; 2016 Feb; 55(2):161-9. PubMed ID: 25594762 [TBL] [Abstract][Full Text] [Related]
5. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling. Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878 [TBL] [Abstract][Full Text] [Related]
6. Protective role of mineralocorticoid receptor signaling in urothelial tumorigenesis. Nagata Y; Matsukawa T; Goto T; Teramoto Y; Jiang G; Fujimoto N; Miyamoto H Am J Cancer Res; 2023; 13(2):408-418. PubMed ID: 36895984 [TBL] [Abstract][Full Text] [Related]
7. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor. Hsu JW; Hsu I; Xu D; Miyamoto H; Liang L; Wu XR; Shyr CR; Chang C Am J Pathol; 2013 May; 182(5):1811-20. PubMed ID: 23499463 [TBL] [Abstract][Full Text] [Related]
8. GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgens. Li Y; Ishiguro H; Kawahara T; Miyamoto Y; Izumi K; Miyamoto H Am J Cancer Res; 2014; 4(5):461-73. PubMed ID: 25232488 [TBL] [Abstract][Full Text] [Related]
9. Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer. Cao L; Zhou XD; Sens MA; Garrett SH; Zheng Y; Dunlevy JR; Sens DA; Somji S J Appl Toxicol; 2010 Jul; 30(5):416-30. PubMed ID: 20186695 [TBL] [Abstract][Full Text] [Related]
10. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice. Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672 [TBL] [Abstract][Full Text] [Related]
11. ERK5 positively regulates cigarette smoke-induced urocystic epithelial-mesenchymal transition in SV‑40 immortalized human urothelial cells. Geng H; Zhao L; Liang Z; Zhang Z; Xie D; Bi L; Wang Y; Zhang T; Cheng L; Yu D; Zhong C Oncol Rep; 2015 Sep; 34(3):1581-8. PubMed ID: 26177962 [TBL] [Abstract][Full Text] [Related]
13. Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN protein degradation resulting from SNHG1 upregulation. Li T; Huang M; Sun N; Hua X; Chen R; Xie Q; Huang S; Du M; Zhao Y; Lin Q; Xu J; Han X; Zhao Y; Tian Z; Zhang Y; Chen W; Shen X; Huang C J Exp Clin Cancer Res; 2024 Feb; 43(1):50. PubMed ID: 38365726 [TBL] [Abstract][Full Text] [Related]
14. Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model. Escudero-Lourdes C; Medeiros MK; Cárdenas-González MC; Wnek SM; Gandolfi JA Toxicol Appl Pharmacol; 2010 Apr; 244(2):162-73. PubMed ID: 20045430 [TBL] [Abstract][Full Text] [Related]
15. Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis. Kawahara T; Inoue S; Kashiwagi E; Chen J; Ide H; Mizushima T; Li Y; Zheng Y; Miyamoto H Am J Cancer Res; 2017; 7(10):2041-2050. PubMed ID: 29119053 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression. Kashiwagi E; Inoue S; Mizushima T; Chen J; Ide H; Kawahara T; Reis LO; Baras AS; Netto GJ; Miyamoto H Br J Cancer; 2018 Jan; 118(2):213-223. PubMed ID: 29123257 [TBL] [Abstract][Full Text] [Related]
17. Attachment of Cancer Urothelial Cells to the Bladder Epithelium Occurs on Uroplakin-Negative Cells and Is Mediated by Desmosomal and Not by Classical Cadherins. Jerman UD; Višnjar T; Bratkovič IH; Resnik N; Pavlin M; Veranič P; Kreft ME Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070317 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma. Brait M; Munari E; LeBron C; Noordhuis MG; Begum S; Michailidi C; Gonzalez-Roibon N; Maldonado L; Sen T; Guerrero-Preston R; Cope L; Parrella P; Fazio VM; Ha PK; Netto GJ; Sidransky D; Hoque MO Cell Cycle; 2013 Apr; 12(7):1058-70. PubMed ID: 23435205 [TBL] [Abstract][Full Text] [Related]
19. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation. Yang J; Platt LT; Maity B; Ahlers KE; Luo Z; Lin Z; Chakravarti B; Ibeawuchi SR; Askeland RW; Bondaruk J; Czerniak BA; Fisher RA Oncotarget; 2016 Oct; 7(43):69159-69172. PubMed ID: 27713144 [TBL] [Abstract][Full Text] [Related]
20. Transformation of human urothelial cells (UROtsa) by as and cd induces the expression of keratin 6a. Somji S; Bathula CS; Zhou XD; Sens MA; Sens DA; Garrett SH Environ Health Perspect; 2008 Apr; 116(4):434-40. PubMed ID: 18414623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]